1. Risk factors for recurrence in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in Japan: a systematic literature review and meta-analysis
   Naoki Miyazaki et al, 2024, Current Medical Research and Opinion CrossRef
2. Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
   Fumine Tsukamoto et al, 2021, BMC Cancer CrossRef